Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
High Risk
100%
Hematological Malignancies
100%
Advanced Stage
100%
Allogeneic Bone Marrow Transplantation
100%
Cyclophosphamide
100%
Etoposide
100%
Fractionated Total Body Irradiation
100%
Acute Leukemia
60%
Disease-free Survival
60%
Prednisone
40%
Chronic Lymphocytic Leukemia
40%
Advanced Disease
40%
Cyclosporine
40%
Complete Remission
40%
Bone Marrow Transplantation
40%
Relapse Rate
40%
Non-Hodgkin Lymphoma
20%
Curative Treatment
20%
VP16
20%
Prospective Clinical Trial
20%
Chronic Myeloid Leukemia
20%
Methotrexate
20%
Treatment Failure
20%
Multiple Organ Failure
20%
Host Disease
20%
Veno-occlusive Disease of the Liver
20%
Accelerated Phase
20%
Adult Respiratory Distress Syndrome
20%
High-grade non-Hodgkin Lymphoma
20%
Diffuse Alveolar Hemorrhage
20%
Myeloablative Therapy
20%
Post-transplant Relapse
20%
GVHD Prophylaxis
20%
Central Nervous System Bleeding
20%
Intensified Regimen
20%
Well Tolerated
20%
Matched Unrelated Donor
20%
Medicine and Dentistry
Hematologic Malignancy
100%
Whole Body Radiation
100%
Cyclophosphamide
100%
Etoposide
100%
Allogenic Bone Marrow Transplantation
100%
Acute Leukemia
60%
Disease Free Survival
60%
Cyclosporine
40%
Recurrence Risk
40%
Bone Marrow Transplantation
40%
Prednisone
40%
Chronic Leukemia
40%
Diseases
40%
Clinical Trial
20%
Graft Versus Host Reaction
20%
Non-Hodgkin Lymphoma
20%
Central Nervous System
20%
Acute Respiratory Distress Syndrome
20%
Methotrexate
20%
Multiple Organ Dysfunction Syndrome
20%
Vein Occlusion
20%
Chronic Myelogenous Leukemia
20%
Patient with Non-Hodgkins Lymphoma
20%
Pulmonary Hemorrhage
20%
Bleeding
20%
Median Follow Up
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Etoposide
100%
Cyclophosphamide
100%
Disease Free Survival
60%
Acute Leukemia
60%
Prednisone
40%
Remission
40%
Nonhodgkin Lymphoma
40%
Ciclosporin
40%
Recurrence Risk
40%
Chronic Leukemia
40%
Diseases
40%
Clinical Trial
20%
Graft Versus Host Reaction
20%
Adult Respiratory Distress Syndrome
20%
Methotrexate
20%
Multiple Organ Failure
20%
Vein Occlusion
20%
Chronic Myeloid Leukemia
20%
Lung Hemorrhage
20%
Immunology and Microbiology
Allogeneic Bone Marrow Transplantation
100%
Cyclophosphamide
100%
Disease Free Survival
75%
Bone Marrow Transplantation
50%
Ciclosporin
50%
Prednisone
50%
Graft-Versus-Host Disease
25%
Central Nervous System
25%
Methotrexate
25%